Descartes-25 in Relapsed/Refractory Multiple Myeloma
Clinical trial NCT05113342 · TERMINATED
Trial details
- NCT number
- NCT05113342
- Sponsor
- Cartesian Therapeutics
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-25
- Primary completion
- 2023-05-09
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.